Cardiac gene delivery with cardiopulmonary bypass

70Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Background - Cardiac gene therapy offers the possibility of enhancing myocardial performance in the compromised heart. However, current gene delivery techniques have limited myocardial transgene expression and pose the risk of extracardiac expression. Isolation of the coronary circulation during cardiac surgery may allow for more efficient and cardiac-selective gene delivery in a clinically relevant model. Methods and Results - Neonatal piglets (3 kg) underwent a median sternotomy and cardiopulmonary bypass, followed by aortic cross-clamping with 30 minutes of cardioplegic arrest. Adenoviral vectors containing transgenes for either β-galactosidase (adeno-β-gal, n=11) or the human β2-adrenergic receptor (adeno-β2-AR, n=15) were administered through the cardioplegia cannula immediately after arrest and were allowed to dwell in the coronary circulation during the cross-clamp period. After 1 week, the animals were killed, and their heart, lungs, and liver were excised and examined for gene expression. Analysis of β-galactosidase staining revealed transmural myocardial gene expression among animals receiving adeno-β-gal. No marker gene expression was detected in liver or lung tissue. β-AR density in the left ventricle after adeno-β2-AR delivery was 396±85% of levels in control animals (P<0.01). Animals receiving adeno-β2-AR and control animals demonstrated similar β-AR density in both the liver (114±8% versus 100±9%, P=NS) and lung (114±7% versus 100±9%, P=NS). There was no evidence of cardiac inflammation. Conclusions - By using cardiopulmonary bypass and cardioplegic arrest, intracoronary delivery of adenoviral vectors resulted in efficient myocardial uptake and expression. Undetectable transgene expression in liver or lung tissue suggests cardiac-selective expression.

References Powered by Scopus

Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor

648Citations
N/AReaders
Get full text

Modulation of ventricular function through gene transfer in vivo

269Citations
N/AReaders
Get full text

Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction

201Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure

184Citations
N/AReaders
Get full text

Mixed signals in heart failure: Cancer rules

149Citations
N/AReaders
Get full text

Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals

127Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Davidson, M. J., Jones, J. M., Emani, S. M., Wilson, K. H., Jaggers, J., Koch, W. J., & Milano, C. A. (2001). Cardiac gene delivery with cardiopulmonary bypass. Circulation, 104(2), 131–133. https://doi.org/10.1161/01.CIR.104.2.131

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

38%

Researcher 4

31%

Professor / Associate Prof. 3

23%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

67%

Agricultural and Biological Sciences 3

20%

Biochemistry, Genetics and Molecular Bi... 1

7%

Nursing and Health Professions 1

7%

Save time finding and organizing research with Mendeley

Sign up for free